Health

Effects of supplementary protection mechanisms for pharmaceutical products

To stimulate the development of new medicines, various forms of ‘supplementary protections’ exist that give companies extended monopoly rights. This includes: Supplementary Protection Certificates (SPCs), which prolong the patent protection for medicinal products by up to five years; paediatric extensions to SPCs; regulatory protection in the form of data and market exclusivity; as well as…

View report

How can the EU Framework Programme for Research and Innovation increase the economic and societal impact of RDI funding in Finland?

Long-term objectives of Finnish research and innovation policy. One objective of the current government is to improve the quality and effectiveness of research and innovation. This study examines what kinds of benefits have been obtained from EU Framework Programmes and how Finnish participation can be further supported. Overall, the FP provides clear added value for…

View report

Strategic Evaluation of the 5 % Initiative

Second greatest contributor to the Global Fund to Fight AIDS, Tuberculosis and Malaria, France has dedicated 5 % (ie. €18m per year) of its contribution to provide technical assistance to the Countries eligible to the Global Fund over the period 2011-2016 to support their access to and the implementation of the Global Fund grants. The…

View report

Interim evaluation of the Rational Pharmacotherapy (GGG-) Programme

In the quest to improve healthcare, new and innovative medicines garner a lot of attention, but making better use of existing medicines is just as important. This can, for instance, mean understanding better which patients benefit from a particular treatment or tackling problems with adherence to medication. This field is known as rational pharmacotherapy. In…

View report

Norwegian participation in Horizon 2020 in health, ICT and industry

The Research Council of Norway (RCN) commissioned Technopolis Group to conduct a study on the possibilities to increase participation in Horizon 2020, but also in relation to other European Research Area activities and future Framework Programmes. The assignment was to focus on the three topic areas of health, Information and Communications Technology, and industry. The…

View report

Evidence on mechanisms and tools for use of health information for decision-making

The World Health Assembly in 2005 urged Member States to establish or strengthen knowledge transfer mechanisms to support evidence-informed health policies and health care delivery. The European Health Information Initiative was set up to strengthen the use of evidence, information and research for policy-making in the WHO European Region. While good-quality health information is a key component for…

View report

Evaluation of the impact of the European Union’s research funding for poverty-related and neglected diseases – Lessons from EU research funding (1998–2013)

Poverty-related and neglected diseases (PRNDs) carry a high burden of morbidity and mortality in low- and middle-income countries (LMICs). Yet, there remains a large unmet need for effective, affordable and safe approaches to combat these diseases. Much of the underpinning research in this field has been carried out by the public sector, with funding provided…

View report

The impact of collaboration: the value of UK medical research to EU science and health

The UK has a strong medical research community; the country’s withdrawal from the European Union (EU) can therefore be expected to have implications not only for the UK, but also for EU science and health. To better understand the UK’s contribution to medical research and patient health in the EU, a new study was commissioned…

View report